Alyeska Investment Group, L.P. Mirum Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $778,727 - $1.26 Million	49,443 Added 98.93%	99,421 $1.74 Million
Q3 2020 Nov 16, 2020	SELL	$18.4 - $26.59 $706,670 - $1.02 Million	-38,406 Reduced 43.45%	49,978 $963,000
Q2 2020 Aug 14, 2020	SELL	$11.51 - $20.97 $659,833 - $1.2 Million	-57,327 Reduced 39.34%	88,384 $1.72 Million
Q1 2020 May 15, 2020	BUY	$9.38 - $23.79 $1.11 Million - $2.82 Million	118,631 Added 438.08%	145,711 $2.04 Million
Q4 2019 Feb 14, 2020	SELL	$6.84 - $25.9 $328,983 - $1.25 Million	-48,097 Reduced 63.98%	27,080 $664,000
Q3 2019 Nov 14, 2019	BUY	$9.16 - $14.77 $688,621 - $1.11 Million	75,177 New	75,177 $756,000

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.61B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.